This brand name is authorized in Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland
The drug ONTILYV contains one active pharmaceutical ingredient (API):
1
Opicapone
UNII Y5929UIJ5N - OPICAPONE
|
Opicapone is a peripheral, selective and reversible catechol-O-methyltransferase (COMT) inhibitor endowed with a high binding affinity (sub-picomolar). Opicapone is indicated as adjunctive therapy to preparations of levodopa/DOPA decarboxylase inhibitors (DDCI) in adult patients with Parkinson’s disease, leading to an increase of levodopa plasma levels thereby improving the clinical response to levodopa. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
ONTILYV Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N04BX04 | N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BX Other dopaminergic agents | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1877283, 1877294, 1877306, 1877317, 1877328, 1877339, 1877340, 1877351, 1877362, 1877373 |
Country: IT | Agenzia del Farmaco | Identifier(s): 049963010, 049963022, 049963034, 049963046, 049963059, 049963061, 049963073, 049963085, 049963097, 049963109 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1094285, 1094286, 1094287, 1094288, 1094289, 1094290, 1094291, 1094292, 1094293, 1094294 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100467786, 100467793 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.